[go: up one dir, main page]

HK1148234A - Device and method for treating central nervous system pathology - Google Patents

Device and method for treating central nervous system pathology Download PDF

Info

Publication number
HK1148234A
HK1148234A HK11102479.3A HK11102479A HK1148234A HK 1148234 A HK1148234 A HK 1148234A HK 11102479 A HK11102479 A HK 11102479A HK 1148234 A HK1148234 A HK 1148234A
Authority
HK
Hong Kong
Prior art keywords
nervous system
central nervous
treating central
system pathology
treating
Prior art date
Application number
HK11102479.3A
Other languages
Chinese (zh)
Inventor
Louis C. Argenta
David L. Carroll
Nicole H. Levi
Jie Liu
Michael J. Morykwas
Stephen Tatter
William D. Wagner
Original Assignee
Wake Forest University Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University Health Sciences filed Critical Wake Forest University Health Sciences
Publication of HK1148234A publication Critical patent/HK1148234A/en

Links

Abstract

The present invention relates generally to a device and method for treating tissues of the central nervous system and more particularly, but not exclusively, to a device and method for treating the brain tissue.
HK11102479.3A 2008-01-09 2009-01-09 Device and method for treating central nervous system pathology HK1148234A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61/019,968 2008-01-09
US61/081,997 2008-07-18

Publications (1)

Publication Number Publication Date
HK1148234A true HK1148234A (en) 2011-09-02

Family

ID=

Similar Documents

Publication Publication Date Title
WO2009132656A3 (en) Crystal structure of human sortilin and uses thereof for identifying ligands to sortilin
WO2008067121A3 (en) Methods of treating cognitive impairment and dementia
MX2010007490A (en) Preparation of sulfamide derivatives.
WO2012083024A8 (en) Treatment of spinal cord injury and traumatic brain injury using placental stem cells
WO2011047091A9 (en) Methods for treating traumatic brain injury
WO2011044537A9 (en) Methods for treating alzheimer's disease
IL207811A0 (en) Kit, composition, product or medicament for treating cognitive impairment
EP2091480A4 (en) System for the treatment of heart tissue
WO2010042292A8 (en) Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease
WO2008121386A3 (en) Calcimimetic compounds for use in the treatment of bowel disorders
IL213120A0 (en) Method for treating parkinson' s disease
WO2010098583A2 (en) Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same
WO2009015369A3 (en) Isophthalamide derivatives inhibiting beta-secretase activity
WO2009102789A3 (en) Use of rxr agonists for the treatment of osteroarthritis
WO2009120368A3 (en) Treatment of brain damage using umbilical cord blood cells
EP2716285A3 (en) New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
EP2255825A4 (en) Composition for preventing or treating brain diseases
WO2009105507A3 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
WO2010054324A3 (en) Methods for treating clinical conditions associated with lipoprotein lipase activity
WO2009158729A3 (en) Compounds and methods for diagnosis and treatment of chagas disease
HK1148234A (en) Device and method for treating central nervous system pathology
ZA201201715B (en) Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo{[2,2.1]hept-5-enes
PT2278962E (en) Methods for the treatment of dermatological disorders
EP1901770A4 (en) Methods for treatment of growth disorders
WO2009140649A3 (en) Rab3b for the treatment and prevention of parkinson's disease